International Linked Clinical Trials Cocktail Reception
Please join us for a cocktail reception to learn more about the International Linked Clinical Trials initiative, a collaborative global effort between Cure Parkinson’s and Van Andel Institute. Each year, more than 60,000 people in the U.S. are diagnosed with Parkinson’s disease. When a potentially life-altering discovery is made, it can take a decade and more than a billion dollars to turn it into an FDA-approved therapy.
That’s why, since 2014, Van Andel Institute has collaborated with Cure Parkinson’s, a U.K.-based research charity that was founded by people with Parkinson’s. Together, we aim to identify new treatments that slow or stop disease progression by exploring medications developed to treat other diseases, an approach that can save precious time and resources.
Business casual attire suggested.
Complimentary valet parking at the main entrance of Van Andel Institute.
Please note: this is invitation only.
Please RSVP by September 21 to Maddie Eaton at [email protected]
Darren Moore, Ph.D., seeks new diagnostic and treatment approaches for Parkinson’s by investigating the inherited form of the disease, which accounts for 5 to 10 percent of cases. He aims to translate the understanding of these genetic mutations into better treatments and new diagnostic tools for Parkinson’s, both inherited and non-inherited. Discoveries in Moore’s lab routinely elucidate the faulty molecular interactions that transform healthy, functioning neurons into diseased ones. Moore is chair of VAI’s Department of Neurodegenerative Science.
Will was appointed CEO of Cure Parkinson’s in 2017, working with and alongside deputy CEO Helen Matthews. Prior to that, he served as a Trustee of the charity and Chair of our Governance & Risk Committee from 2015.
Will has been a supporter of the charity since its inception in 2005, although his involvement dates back to 2002. He was Chair of the charity fundraising committee supporting Tom Isaacs’ 4,500 mile charity walk (Coastin’) which resulted in the foundation of Cure Parkinson’s.
Will is a a UK-qualified attorney-at-law (an English private practice lawyer or “solicitor”) by profession, having been a partner of City firm Simmons & Simmons and intellectual property specialists Marks & Clerk during his 28-year career. He retired from partnership in 2018, but remains active for Marks & Clerk as its Senior Counsel and as a consultant in several areas of IP law.
Event Details
Contact Info:
Email: Maddie Eaton